MEDESIS PHARMA PRESENTS A SCIENTIFIC POSTER AT THE CLINICAL TRIALS ON ALZHEIMER'S DISEASE CONFERENCE IN SAN FRANCISCO

28 Nov 2022 18:00 CET

Subscribe
Issuer

MEDESIS PHARMA S.A.

See attachment(s) / Voir document(s) joint(s) / Zie bijlage / Ver documento(s) em anexo

16165_1121951_MEDESIS_PHARMA_CP_CTADNovembre2022_EN.pdf

Source

MEDESIS PHARMA

Provider

Les Echos

Company Name

MEDESIS PHARMA S.A.

ISIN

FR0010844464

Symbol

ALMDP

Market

Euronext Growth

Attachments

Disclaimer

Medesis Pharma SA published this content on 28 November 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 28 November 2022 17:07:09 UTC.